These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2801678)

  • 1. Lipolytic activity of Campylobacter pylori: effect of colloidal bismuth subcitrate (De-Nol).
    Slomiany BL; Kasinathan C; Slomiany A
    Am J Gastroenterol; 1989 Oct; 84(10):1273-7. PubMed ID: 2801678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipolytic activity of Campylobacter pylori: effect of sofalcone.
    Slomiany BL; Nishikawa H; Piotrowski J; Okazaki K; Slomiany A
    Digestion; 1989; 43(1-2):33-40. PubMed ID: 2806755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulglycotide effect on the proteolytic and lipolytic activities of Helicobacter pylori toward gastric mucus.
    Piotrowski J; Czajkowski A; Yotsumoto F; Slomiany A; Slomiany BL
    Am J Gastroenterol; 1994 Feb; 89(2):232-6. PubMed ID: 8304309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colloidal bismuth subcitrate (De-Nol) inhibits degradation of gastric mucus by Campylobacter pylori protease.
    Sarosiek J; Bilski J; Murty VL; Slomiany A; Slomiany BL
    Am J Gastroenterol; 1989 May; 84(5):506-10. PubMed ID: 2470250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of sucralfate on the degradation of human gastric mucus by Helicobacter pylori protease and lipases.
    Slomiany BL; Piotrowski J; Slomiany A
    Am J Gastroenterol; 1992 May; 87(5):595-9. PubMed ID: 1595646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colloidal bismuth subcitrate inhibits peptic degradation of gastric mucus and epidermal growth factor in vitro.
    Slomiany BL; Nishikawa H; Bilski J; Slomiany A
    Am J Gastroenterol; 1990 Apr; 85(4):390-3. PubMed ID: 2109526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ebrotidine effect on the proteolytic and lipolytic activities of Helicobacter pylori.
    Slomiany BL; Piotrowski J; Mojtahed H; Slomiany A
    Gen Pharmacol; 1992 Mar; 23(2):203-6. PubMed ID: 1639232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Campylobacter pyloridis degrades mucin and undermines gastric mucosal integrity.
    Slomiany BL; Bilski J; Sarosiek J; Murty VL; Dworkin B; VanHorn K; Zielenski J; Slomiany A
    Biochem Biophys Res Commun; 1987 Apr; 144(1):307-14. PubMed ID: 3579908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement in gastric mucus gel qualities with colloidal bismuth subcitrate administration.
    Piotrowski J; Bilski J; Nishikawa H; Slomiany A; Slomiany BL
    Eur J Pharmacol; 1990 Aug; 184(1):55-63. PubMed ID: 2209715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of bismuth subcitrate on amphibian gastroduodenal bicarbonate secretion.
    Shorrock CJ; Crampton JR; Gibbons LC; Rees WD
    Gut; 1989 Jul; 30(7):917-21. PubMed ID: 2788112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The minimum inhibitory concentrations of various bismuth salts against Campylobacter pylori.
    Vogt K; Warrelmann M; Hahn H
    Zentralbl Bakteriol; 1989 Sep; 271(3):304-10. PubMed ID: 2803458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of the modes of action of colloidal bismuth subcitrate.
    Hall DW
    Scand J Gastroenterol Suppl; 1989; 157():3-6; discussion 21-2. PubMed ID: 2665050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibacterial action of bismuth in relation to Campylobacter pyloridis colonization and gastritis.
    Marshall BJ; Armstrong JA; Francis GJ; Nokes NT; Wee SH
    Digestion; 1987; 37 Suppl 2():16-30. PubMed ID: 3622946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of Helicobacter pylori pathogenesis: focus on mucus.
    Slomiany BL; Slomiany A
    J Clin Gastroenterol; 1992; 14 Suppl 1():S114-21. PubMed ID: 1378466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for weakening of gastric mucus integrity by Campylobacter pylori.
    Sarosiek J; Slomiany A; Slomiany BL
    Scand J Gastroenterol; 1988 Jun; 23(5):585-90. PubMed ID: 3399831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-ulcer dyspepsia and short term De-Nol therapy: a placebo controlled trial with particular reference to the role of Campylobacter pylori.
    Rokkas T; Pursey C; Uzoechina E; Dorrington L; Simmons NA; Filipe MI; Sladen GE
    Gut; 1988 Oct; 29(10):1386-91. PubMed ID: 3058555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphologic evaluation of gastric mucosal protection by colloidal bismuth subcitrate (De-Nol).
    van den Hoven WE; Birtwhistle RD; Hall DW
    Int J Tissue React; 1988; 10(5):297-304. PubMed ID: 3250943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colloidal bismuth subcitrate evokes adaptive cytoprotection in rat gastric mucosa.
    Balint GA
    Acta Med Hung; 1991; 48(3-4):197-201. PubMed ID: 1822857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastric mucosa protective effects of colloidal bismuth subcitrate (DE-NOL).
    Hall DW; van den Hoven WE
    Int J Tissue React; 1987; 9(5):427-32. PubMed ID: 3478321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitivity of Campylobacter pylori to colloidal bismuth subcitrate.
    Goodwin CS; Bell B; McCullough C; Turner M
    J Clin Pathol; 1989 Feb; 42(2):216-7. PubMed ID: 2921366
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.